SCHEMBL3786335

SCHEMBL3786335

Cc1cc(-c2cccc(N)c2)ccc1N

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.71
TSHR P16473 2/20 0.71
ALDH1A1 P00352 2/20 0.71
TDP1 Q9NUW8 1/20 0.71
MAP4K4 O95819 6/20 0.58
MAOA P21397 1/20 0.56
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
MEN1 O00255 1/20 0.46
PSIP1 O75475 1/20 0.46
AXL P30530 1/20 0.46
MKNK1 Q9BUB5 1/20 0.46
MKNK2 Q9HBH9 1/20 0.46
RECQL P46063 2/20 0.44
CASP1 P29466 2/20 0.44
CYP17A1 P05093 2/20 0.43
CYP19A1 P11511 2/20 0.43
CYP11B1 P15538 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Orthotolidine SCHEMBL9650002 0.88 CYP3A4 (0.55) CYP3A4TSHRALDH1A1TDP1MAP4K4
Orthotolidine SCHEMBL49414 0.84 CYP3A4 (1.00) CYP3A4TSHRALDH1A1TDP1MEN1
Orthotolidine SCHEMBL29365329 0.84 CYP3A4 (1.00) CYP3A4TSHRALDH1A1TDP1MEN1
Orthotolidine SCHEMBL29386552 0.84 CYP3A4 (1.00) CYP3A4TSHRALDH1A1TDP1MEN1
SCHEMBL25261675 0.83 ALDH1A1 (0.71) CYP3A4TSHRALDH1A1TDP1MAP4K4
SCHEMBL3792051 0.83 CASP1 (0.58) CYP3A4TSHRALDH1A1TDP1MAP4K4
Hydrochloric Acid SCHEMBL1569886 0.83 MAP4K4 (0.58) CYP3A4TSHRALDH1A1TDP1MAP4K4
SCHEMBL29943184 0.83 ALDH1A1 (0.71) CYP3A4TSHRALDH1A1TDP1MAP4K4
SCHEMBL807858 0.83 TDP1 (0.77) CYP3A4TSHRALDH1A1TDP1MAOA
Orthotolidine SCHEMBL20547383 0.82 CYP3A4 (0.94) CYP3A4TSHRALDH1A1TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 CYP3A4 177/4885TSHR 1688/4885ALDH1A1 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.